FMI: Liquid Biopsy in Advanced Prostate Cancer: Stay Up to Date
Meeting Host
Foundation Medicine®Description
When
March 28, 2024 | 12:00, 1:00 or 6:00 pm ET
Where
Webinar
Description
When a liquid biopsy report identifies a targetable driver, treatment decisions are clear. When there is no driver identified, the next steps are more uncertain. Expert speakers will present their perspectives on liquid biopsy for treatment selection in prostate cancer and discuss emerging biomarker ctDNA tumor fraction reported on Foundation Medicine's liquid biopsy test.
